POVIDONE K30

Unresolved Excipient

Suggest One No specific molecular structure known for this excipient.
CAS
9003398
UNII
U725QWY32X
SYNONYMS
ZINC ID(s)
Availability
Present in 0 ZINC catalogs

Known Active Genes

There has not been any activity reported at 10μM or less for this excipient (per ChEBML)

Clinical Trials

This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).

(Browse) Purchasable Analogs in ZINC

Analogs cannot be located as there is no structure provided for this compound. Try a search by name.

Dosages

Route Formulation Per Unit Dose
Ophthalmic Solution 2%
Ophthalmic Solution, Drops 2%
Ophthalmic Suspension 0.6%
Oral Capsule 20MG
Oral Capsule, Delayed Action 12MG
Oral Capsule, Enteric Coated Pellets 26.8MG
Oral Capsule, Extended Release 24MG
Oral Capsule, Gelatin Coated 21MG
Oral Capsule, Hard Gelatin 10MG
Oral Capsule, Soft Gelatin 30MG
Oral Capsule, Soft Gelatin Liquid-Filled 25.2MG
Oral Capsule, Sustained Action 6.88MG
Oral Dispersible Tablet 51.2MG
Oral Granule, Effervescent
Oral Liquid 1%
Oral Powder, For Oral Solution 5MG
Oral Powder, For Suspension 0.26%
Oral Suspension 6.71MG
Oral Tablet 80MG
Oral Tablet (immed./comp. Release), Coated 8MG
Oral Tablet (immed./comp. Release), Film Coated 8.8MG
Oral Tablet (immed./comp. Release), Uncoated, Chewable 9MG
Oral Tablet (immed./comp. Release), Uncoated, Effervescent 40MG
Oral Tablet, Coated 14.5MG
Oral Tablet, Controlled Release 14.5MG
Oral Tablet, Delayed Action 24MG
Oral Tablet, Delayed Action, Coated 35MG
Oral Tablet, Delayed Action, Enteric Coated 27.2MG
Oral Tablet, Delayed Release 8.25MG
Oral Tablet, Dispersible 3MG
Oral Tablet, Extended Release 50MG
Oral Tablet, Film Coated 42MG
Oral Tablet, Orally Disintegrating 35.71MG
Oral Tablet, Sustained Action 55MG
Oral-21 Tablet 5MG
Oral-28 Tablet 6MG
Sublingual Tablet 10MG
Topical Patch, Controlled Release
Transdermal Film 5.11MG

More Information

Usage Over Time

Comments